BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

Intra-Cellular raises $295M In an offering priced late Tuesday, Intra-Cellular Therapies Inc. (NASDAQ:ITCI) raised $295 million through the sale of 10 million shares at $29.50. The price is a 4% discount to Intra-Cellular’s close at...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

Kodiak in $225M royalty deal with Baker Bros. Kodiak Sciences Inc. (NASDAQ:KOD) gained $21.45 (72%) to $51.05 on Monday after selling royalty rights on global net sales of retinal vascular disease drug KSI-301 to Baker...
BioCentury | Apr 5, 2019
Company News

Hangzhou Just licenses Lilly’s bone disease program

Transcenta Holding’s subsidiary Hangzhou Just Biotherapeutics gained exclusive greater China rights from Lilly to develop and commercialize a portfolio of biologics, including blosozumab, for bone disease. Eli Lilly and Co. (NYSE:LLY) will receive an undisclosed...
BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

Inovio CMO Mark Bagarazzi has left the company. Inovio Pharmaceuticals Inc. (NASDAQ:INO) said a newly formed medical council -- VPs of Clinical Development Prakash Bhuyan, Jeffrey Skolnik and Scott White -- will now oversee the...
BioCentury | Jan 4, 2019
Company News

Hangzhou Just, MabSpace merging

Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) and MabSpace Biosciences Co. Ltd. (Hong Kong, China) announced on Jan. 1 that the companies will merge to create Transcenta Holding Ltd. The companies said Transcenta will have a...
BioCentury | Jan 2, 2019
Company News

Hangzhou Just, MabSpace merging

Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) and MabSpace Biosciences Co. Ltd. (Hong Kong, China) announced on Tuesday that the companies will merge to create Transcenta Holding Ltd. The companies said Transcenta will have a global...
Items per page:
1 - 6 of 6
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

Intra-Cellular raises $295M In an offering priced late Tuesday, Intra-Cellular Therapies Inc. (NASDAQ:ITCI) raised $295 million through the sale of 10 million shares at $29.50. The price is a 4% discount to Intra-Cellular’s close at...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

Kodiak in $225M royalty deal with Baker Bros. Kodiak Sciences Inc. (NASDAQ:KOD) gained $21.45 (72%) to $51.05 on Monday after selling royalty rights on global net sales of retinal vascular disease drug KSI-301 to Baker...
BioCentury | Apr 5, 2019
Company News

Hangzhou Just licenses Lilly’s bone disease program

Transcenta Holding’s subsidiary Hangzhou Just Biotherapeutics gained exclusive greater China rights from Lilly to develop and commercialize a portfolio of biologics, including blosozumab, for bone disease. Eli Lilly and Co. (NYSE:LLY) will receive an undisclosed...
BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

Inovio CMO Mark Bagarazzi has left the company. Inovio Pharmaceuticals Inc. (NASDAQ:INO) said a newly formed medical council -- VPs of Clinical Development Prakash Bhuyan, Jeffrey Skolnik and Scott White -- will now oversee the...
BioCentury | Jan 4, 2019
Company News

Hangzhou Just, MabSpace merging

Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) and MabSpace Biosciences Co. Ltd. (Hong Kong, China) announced on Jan. 1 that the companies will merge to create Transcenta Holding Ltd. The companies said Transcenta will have a...
BioCentury | Jan 2, 2019
Company News

Hangzhou Just, MabSpace merging

Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) and MabSpace Biosciences Co. Ltd. (Hong Kong, China) announced on Tuesday that the companies will merge to create Transcenta Holding Ltd. The companies said Transcenta will have a global...
Items per page:
1 - 6 of 6